Information system of Universität Kiel
© Config eG
Collection/class schedule
Home
|
Contact
|
Help
search:
People
Departments
Other entries
Lecture list
Rooms
Publications
Research projects
Events calendar
Lectures
Staff/
Facilities
Room
directory
Research-
report
Publications
Phone
book
Layout
printable version
verbose list
Also in UnivIS
lecture directory
events calendar
Organization
>>
Schleswig-Holstein University Hospital (UK-SH), Campus Kiel
>>
Department of General Surgery and Thoracic Surgery
2008
Anti-apoptotic and growth-stimmulatory functions of CK1 delta and epsilon in ductal Adeno carcionoma of the pancreas are inhibited by IC261 in vitro an in vivo
Anti-Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo
Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice
Investigation of cholangiocarcinoma associated NKG2D polymorphisms in colorectal carcinoma
2007
Antitumor activity of ALK1 in pancreatic carcinoma cells
Crnogorac-Jurcevic, T., N. R. Lemoine. 2007. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta(4) integrin and the PI3k pathway
Detection of tumor stem cell markers in pancreatic carcinoma cell lines
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function
Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition
Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells
Superiority of Extended Neoadjuvant Chemotherapy with Gemcitabine in Pancreatic Cancer
2006
A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma
Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model
Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells
Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
2005
. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase
. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells
Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival
Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells
Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells
Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis
Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes
Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma
Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by
Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta
2004
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation
Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR
Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors
Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis
O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma
Resistance developing after long-term ganciclovir prodrug treatment in apreclinical model of NSCLC
Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis
Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma
Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta
UnivIS is a product of
Config eG
, Buckenhof